[New post] AstraZeneca (AZN) Up on Enhertu, Imfinzi Cancer Data at ESMO (Revised)

Editorial Team posted: "AstraZeneca's (AZN) Enhertu reduces the risk of disease progression by 72% in HER2-positive metastatic breast cancer. Imfinzi plus chemotherapy triple... Find out more at https://ift.tt/3ijV9J2 via Entrepreneur.com" New post on Technology & Business News AstraZeneca (AZN) Up on Enhertu, Imfinzi Cancer Data at ESMO (Revised) by Editorial Team AstraZeneca's (AZN) Enhertu reduces the risk of disease progression by 72% in HER2-positive metastatic breast cancer. Imfinzi plus chemotherapy triple... Find out more at https://ift.tt/3ijV9J2 via Entrepreneur.com Read more of this post This free site is ad-supported. Learn more ​ Editorial Team | September 30, 2021 at 3:10 am | Tags: Entrepreneur | Categories: Business | URL: https://wp.me/pcbvJV-9Rg Like Unsubscribe to no longer receive posts from Technology & Business News. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://technologyandbusinessnews.wordpress.com/2021/09/30/astrazeneca-azn-up-on-enhertu-imfinzi-cancer-data-at-esmo-revised/ Thanks for flying with WordPress.com